Skip to main content

Not investment advice.Read full disclaimer

RNAZ: TransCode Therapeutics, Inc. Company Profile & Overview | finqOS

Healthcare · Biotechnology

52W Range

10thpctl

Volume

0.37×avg

Market Cap

5.24MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Continue with finqOS

Get the full profile on TransCode Therapeutics, Inc.

Executive team, business description, key stats, and everything you need to understand the company.

Start Free Trial→Sign In

14-day free trial · No credit card required

TransCode Therapeutics, Inc.

RNAZNASDAQ Capital Market·USD·Closed

TransCode Therapeutics, Inc.

RNAZNASDAQ·USD·Closed

$5.51

+10.64%

$5.51

+$0.53 (10.64%)

52W Range

10thpctl

Volume

0.37×avg

Mkt Cap

5.24MUSD

P/E

-0.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings